Macrogenics Inc (NAS:MGNX)
$ 3.06 -0.22 (-6.71%) Market Cap: 191.93 Mil Enterprise Value: 100.36 Mil PE Ratio: 0 PB Ratio: 3.33 GF Score: 51/100

MacroGenics Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 08:45PM GMT
Release Date Price: $28.32 (+2.50%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Okay. Good afternoon, and welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech equity analyst at Barclays. I just wanted to thank everyone for taking the time out in the day today. You can e-mail me with questions, [email protected], or you can always ping me on Bloomberg.

Gives me a great pleasure to introduce the management team from MacroGenics. So Scott Koenig, thank you so much.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

I guess my initial question is always around the differentiation in the oncology space. So maybe you could talk through what you view as the point of differentiation for the company and kind of the key strengths.

Scott Koenig
MacroGenics, Inc. - CEO, President & Director

Well, thank you very much, Peter. It's always a pleasure speaking with you, and thanks for the Barclays for hosting us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot